TECHNOLOGY SUMMARY

Dr. Sarah Heilshorn's lab at Stanford University has developed a platform for 3D bioprinting which stiffens the structure post-printing using chemistry that is completely bioorthogonal.

AREA/MATURITY/AWARDS

Primary Application Area: Materials, Chemical

Technology Development Status: Concept

Technology Readiness Level: TRL 1

Vetted Programs/Awards: To the best of my knowledge, there is no other awards except the NSF grant.

SHOWCASE SUMMARY

Organization Type: Academic/Gov Lab

Website: https://otl.stanford.edu/

MARKET KEYWORDS

Market Keywords: 3D Bioprinting, Drug Discovery Tissue Models